🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 9 of 78

  1. US 11471460

    Autophagy modulators for use in treating cancer

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11471528

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11471443

    Anti-flavivirus compounds and methods of use

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11465972

    Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use thereof

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11464801

    Compositions and methods for treating cancer with anti-CD33 immunotherapy

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11465993

    Water soluble novel cyanine fluorophore with tunable properties between near IR and SWIR region for in vivo imaging

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11466071

    HLA class I-restricted t cell receptors against mutated RAS

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11464845

    Neisseria meningitidis immunogenic compositions

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11459308

    Broad spectrum inhibitors of filoviruses

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11459320

    Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disorders

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11459360

    Recombinant HIV-1 envelope proteins and their use

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11453725

    Methods for DNA-dependent targeting of a cell permeant antibody

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11453719

    Compositions and methods for treating cancer with anti-ROR1 immunotherapy

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11447541

    Anti-coronavirus antibodies and methods of use

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11447797

    AAV with unique capsid protein VP1 and methods of using for treatment

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11446331

    Wound healing and tissue engineering

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11446238

    Injectable dendrimer hydrogel nanoparticles

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11440951

    Therapeutic antibodies to Marburg virus

    Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11440956

    Anti-thyroglobulin T cell receptors

    Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11440963

    Combination PDL1 and TGF-beta blockade in patients with HPV+ malignancies

    Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11439658

    Compositions and methods for suppressing MSUT2

    Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11441122

    Regulatory T cell epitopes

    Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11441184

    Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (IPSCs)

    Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11434268

    Vascular endothelial growth factor antagonists

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11434272

    Anti-human papillomavirus 16 E7 T cell receptors

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11427581

    JAK inhibitor and use thereof

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11426415

    Treatment for Wolfram syndrome and other endoplasmic reticulum stress disorders

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11426385

    Methods of improving cancer chemotherapy

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11414379

    SPAK kinase inhibitors as neuroprotective agents

    Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11407818

    Antibodies that bind to dengue virus serotype 4 (DENV4) and methods of making and using the same

    Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11406646

    Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

    Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11400150

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11401503

    Methods of growing tumor infiltrating lymphocytes in gas-permeable containers

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11389415

    Methods of regulating cannabinoid receptor activity-related disorders and diseases

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11389400

    Aerosilization of stem cells or stem cell derivatives for pulmonary delivery

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11390683

    Anti-mesothelin polypeptides and proteins

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11389480

    Human monoclonal antibody targeting TNFR2 for cancer immunotherapy

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11385201

    Ultra-stable protein ionic liquids

    Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11382976

    Ultra-stable protein ionic liquids

    Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11384139

    Antibody targeting cell surface deposited complement protein C3d and use thereof

    Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11376318

    Methods of preparing anti-human papillomavirus antigen t cells

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11377660

    Chimeric antigen receptors targeting B-cell maturation antigen

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11370828

    Anti-coronavirus antibodies and methods of use

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11369675

    Broadly protective inactivated influenza virus vaccine

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11369697

    Liposome nanoparticles for tumor magnetic resonance imaging

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11371024

    Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11369674

    Treatment method utilizing chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E2 and E1 structural proteins

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11364211

    Methods for selecting phosphatase selective and non-selective phosphatase inhibitors

    Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.